{"id":644,"date":"2026-03-12T17:26:20","date_gmt":"2026-03-12T16:26:20","guid":{"rendered":"https:\/\/biotechlerncenter.iph-multisite.berta-bewegt.ch\/?page_id=644"},"modified":"2026-03-12T17:26:20","modified_gmt":"2026-03-12T16:26:20","slug":"8-intensifier-la-recherche","status":"publish","type":"page","link":"https:\/\/biotechlerncenter.interpharma.ch\/fr\/sujets\/les-antibiotiques-sauvent-des-vies\/8-intensifier-la-recherche\/","title":{"rendered":"8. Intensifier la recherche"},"content":{"rendered":"\n<p>Ces trente derni\u00e8res ann\u00e9es, seuls deux nouveaux groupes d\u2019antibiotiques ont \u00e9t\u00e9 mis sur le march\u00e9. Cela est d\u00fb d\u2019une part au fait que l\u2019on a longtemps cru avoir pratiquement vaincu les bact\u00e9ries. D\u2019autre part, les antibiotiques ne sont pas tr\u00e8s rentables pour l\u2019industrie pharmaceutique. Les traitements aux antibiotiques sont relativement courts, donc moins int\u00e9ressants que des m\u00e9dicaments qu\u2019il faut prendre pendant des ann\u00e9es. En outre, il y a toujours le risque que les bact\u00e9ries d\u00e9veloppent une r\u00e9sistance au nouvel antibiotique de sorte que les investissements ne seront finalement pas rentables financi\u00e8rement.<\/p>\n\n\n\n<p>En d\u00e9pit de ces obstacles, le probl\u00e8me des r\u00e9sistances s\u2019\u00e9tant accentu\u00e9, la recherche sur les antibiotiques a \u00e9t\u00e9 renforc\u00e9e ces derni\u00e8res ann\u00e9es. C\u2019est ainsi que, dans la lutte contre les bact\u00e9ries multir\u00e9sistantes, l\u2019entreprise pharmaceutique Roche coop\u00e8re par exemple avec Polyphor, une petite entreprise de biotechnologie, dans le but d\u2019\u00e9laborer un nouvel antibiotique contre le germe multir\u00e9sistant Pseudomonas aeruginosa (susceptible de causer des pneumonies). De m\u00eame, l\u2019entreprise b\u00e2loise BioVersys AG travaille sur de nouvelles substances actives qui devraient r\u00e9duire les r\u00e9sistances aux m\u00e9dicaments contre la tuberculose.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ces trente derni\u00e8res ann\u00e9es, seuls deux nouveaux groupes d\u2019antibiotiques ont \u00e9t\u00e9 mis sur le march\u00e9. Cela est d\u00fb d\u2019une part au fait que l\u2019on a longtemps cru avoir pratiquement vaincu les bact\u00e9ries. D\u2019autre part, les antibiotiques ne sont pas tr\u00e8s rentables pour l\u2019industrie pharmaceutique. Les traitements aux antibiotiques sont relativement courts, donc moins int\u00e9ressants que [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":1254,"menu_order":7,"comment_status":"closed","ping_status":"closed","template":"page-templates\/unterthema.php","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"class_list":["post-644","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>8. Intensifier la recherche - biotechlerncenter<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/biotechlerncenter.interpharma.ch\/themen\/lebensretter-antibiotika\/8-forschung-muss-intensiviert-werden\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"8. Intensifier la recherche\" \/>\n<meta property=\"og:description\" content=\"Ces trente derni\u00e8res ann\u00e9es, seuls deux nouveaux groupes d\u2019antibiotiques ont \u00e9t\u00e9 mis sur le march\u00e9. Cela est d\u00fb d\u2019une part au fait que l\u2019on a longtemps cru avoir pratiquement vaincu les bact\u00e9ries. D\u2019autre part, les antibiotiques ne sont pas tr\u00e8s rentables pour l\u2019industrie pharmaceutique. Les traitements aux antibiotiques sont relativement courts, donc moins int\u00e9ressants que [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/biotechlerncenter.interpharma.ch\/themen\/lebensretter-antibiotika\/8-forschung-muss-intensiviert-werden\/\" \/>\n<meta property=\"og:site_name\" content=\"biotechlerncenter\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/biotechlerncenter.interpharma.ch\/themen\/lebensretter-antibiotika\/8-forschung-muss-intensiviert-werden\/\",\"url\":\"https:\/\/biotechlerncenter.interpharma.ch\/themen\/lebensretter-antibiotika\/8-forschung-muss-intensiviert-werden\/\",\"name\":\"8. Intensifier la recherche - biotechlerncenter\",\"isPartOf\":{\"@id\":\"https:\/\/biotechlerncenter.interpharma.ch\/#website\"},\"datePublished\":\"2026-03-12T16:26:20+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/biotechlerncenter.interpharma.ch\/themen\/lebensretter-antibiotika\/8-forschung-muss-intensiviert-werden\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/biotechlerncenter.interpharma.ch\/themen\/lebensretter-antibiotika\/8-forschung-muss-intensiviert-werden\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/biotechlerncenter.interpharma.ch\/themen\/lebensretter-antibiotika\/8-forschung-muss-intensiviert-werden\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Start\",\"item\":\"https:\/\/biotechlerncenter.interpharma.ch\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sujets\",\"item\":\"https:\/\/biotechlerncenter.interpharma.ch\/fr\/sujets\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Les antibiotiques sauvent des vies\",\"item\":\"https:\/\/biotechlerncenter.interpharma.ch\/fr\/sujets\/les-antibiotiques-sauvent-des-vies\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"8. Intensifier la recherche\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/biotechlerncenter.interpharma.ch\/#website\",\"url\":\"https:\/\/biotechlerncenter.interpharma.ch\/\",\"name\":\"biotechlerncenter\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/biotechlerncenter.interpharma.ch\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"8. Intensifier la recherche - biotechlerncenter","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/biotechlerncenter.interpharma.ch\/themen\/lebensretter-antibiotika\/8-forschung-muss-intensiviert-werden\/","og_locale":"fr_FR","og_type":"article","og_title":"8. Intensifier la recherche","og_description":"Ces trente derni\u00e8res ann\u00e9es, seuls deux nouveaux groupes d\u2019antibiotiques ont \u00e9t\u00e9 mis sur le march\u00e9. Cela est d\u00fb d\u2019une part au fait que l\u2019on a longtemps cru avoir pratiquement vaincu les bact\u00e9ries. D\u2019autre part, les antibiotiques ne sont pas tr\u00e8s rentables pour l\u2019industrie pharmaceutique. Les traitements aux antibiotiques sont relativement courts, donc moins int\u00e9ressants que [&hellip;]","og_url":"https:\/\/biotechlerncenter.interpharma.ch\/themen\/lebensretter-antibiotika\/8-forschung-muss-intensiviert-werden\/","og_site_name":"biotechlerncenter","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/biotechlerncenter.interpharma.ch\/themen\/lebensretter-antibiotika\/8-forschung-muss-intensiviert-werden\/","url":"https:\/\/biotechlerncenter.interpharma.ch\/themen\/lebensretter-antibiotika\/8-forschung-muss-intensiviert-werden\/","name":"8. Intensifier la recherche - biotechlerncenter","isPartOf":{"@id":"https:\/\/biotechlerncenter.interpharma.ch\/#website"},"datePublished":"2026-03-12T16:26:20+00:00","breadcrumb":{"@id":"https:\/\/biotechlerncenter.interpharma.ch\/themen\/lebensretter-antibiotika\/8-forschung-muss-intensiviert-werden\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/biotechlerncenter.interpharma.ch\/themen\/lebensretter-antibiotika\/8-forschung-muss-intensiviert-werden\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/biotechlerncenter.interpharma.ch\/themen\/lebensretter-antibiotika\/8-forschung-muss-intensiviert-werden\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Start","item":"https:\/\/biotechlerncenter.interpharma.ch\/fr\/"},{"@type":"ListItem","position":2,"name":"Sujets","item":"https:\/\/biotechlerncenter.interpharma.ch\/fr\/sujets\/"},{"@type":"ListItem","position":3,"name":"Les antibiotiques sauvent des vies","item":"https:\/\/biotechlerncenter.interpharma.ch\/fr\/sujets\/les-antibiotiques-sauvent-des-vies\/"},{"@type":"ListItem","position":4,"name":"8. Intensifier la recherche"}]},{"@type":"WebSite","@id":"https:\/\/biotechlerncenter.interpharma.ch\/#website","url":"https:\/\/biotechlerncenter.interpharma.ch\/","name":"biotechlerncenter","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/biotechlerncenter.interpharma.ch\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/biotechlerncenter.interpharma.ch\/fr\/wp-json\/wp\/v2\/pages\/644","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/biotechlerncenter.interpharma.ch\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/biotechlerncenter.interpharma.ch\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/biotechlerncenter.interpharma.ch\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/biotechlerncenter.interpharma.ch\/fr\/wp-json\/wp\/v2\/comments?post=644"}],"version-history":[{"count":1,"href":"https:\/\/biotechlerncenter.interpharma.ch\/fr\/wp-json\/wp\/v2\/pages\/644\/revisions"}],"predecessor-version":[{"id":645,"href":"https:\/\/biotechlerncenter.interpharma.ch\/fr\/wp-json\/wp\/v2\/pages\/644\/revisions\/645"}],"up":[{"embeddable":true,"href":"https:\/\/biotechlerncenter.interpharma.ch\/fr\/wp-json\/wp\/v2\/pages\/1254"}],"wp:attachment":[{"href":"https:\/\/biotechlerncenter.interpharma.ch\/fr\/wp-json\/wp\/v2\/media?parent=644"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}